SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-15216"
 

Search: onr:"swepub:oai:DiVA.org:umu-15216" > Expression of p63, ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.

Boldrup, Linda (author)
Umeå universitet,Patologi
Coates, Philip J (author)
Hedberg, Ylva (author)
Umeå universitet,Patologi,Biomedicinsk laboratorievetenskap
show more...
Sjöström, Björn (author)
Umeå universitet,Öron- näs- och halssjukdomar
Dahlqvist, Åke (author)
Umeå universitet,Öron- näs- och halssjukdomar
Nylander, Karin (author)
Umeå universitet,Patologi
show less...
 (creator_code:org_t)
2005
2005
English.
In: International Journal of Oncology. - 1019-6439 .- 1791-2423. ; 27:6, s. 1661-1667
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Squamous cell carcinoma of the head and neck (SCCHN), the 6th most common malignancy in the world, is associated with smoking and has a low 5-year survival rate. Various changes have been described at different stages of SCCHN tumour development, including overexpression of p63, a protein important for development of normal epidermal structures. p63 has been suggested to activate beta-catenin, and nuclear accumulation of beta-catenin is an important event in many cancers. Elevated COX-2 activity and overexpression of EGFR protein has been shown in a variety of human cancers, including SCCHN. An important question for the pathogenesis of SCCHN is when the genetic changes take place during the natural course of the disease, and whether they appear in clinically normal oral mucosa to predispose tumour development. We mapped the expression of p63, COX-2, EGFR, beta-catenin, and PP2A in oral mucosa from smokers/non-smokers and from patients with SCCHN. We also considered if changes occurring in tumours are present in the clinically normal tissue adjacent to the tumour. No direct influence of heavy smoking on the levels of the proteins studied could be seen. Tumours and clinically normal non-neoplastic tissue from SCCHN patients showed increased expression of COX-2 and PP2A. Interestingly, non-neoplastic tissue adjacent to SCCHN also showed increased beta-catenin, although this was not seen in tumours. The data support the notion that pre-existing alterations in clinically normal epithelium exist in patients with SCCHN and could be important for the pathogenesis of the disease and for local recurrences.

Keyword

Adult
Aged
Aged; 80 and over
Blotting; Western
Carcinoma; Squamous Cell/genetics/metabolism/*pathology
Cyclooxygenase 2/genetics/metabolism
DNA-Binding Proteins
Female
Genes; Tumor Suppressor
Head and Neck Neoplasms/genetics/metabolism/*pathology
Humans
Male
Membrane Proteins/genetics/metabolism
Middle Aged
Mouth Mucosa/*metabolism
Phosphoprotein Phosphatase
Phosphoproteins/metabolism
RNA; Messenger/genetics/metabolism
Receptor; Epidermal Growth Factor/metabolism
Reverse Transcriptase Polymerase Chain Reaction
Smoking
Trans-Activators/metabolism
Tumor Markers; Biological/genetics/*metabolism
Tumor Suppressor Proteins
beta Catenin/metabolism

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view